Earlier patient access to beneficial therapeutics that addresses unmet need is one of the main requirements of innovation in global healthcare systems already burdened by unsustainable budgets. “Adaptive pathways” encompass earlier cross-stakeholder engagement, regulatory tools, and iterative evidence generation through the life cycle of the medicinal product. A key enabler of earlier patient access is through more flexible and adaptive payer approaches to pricing and reimbursement that reflect the emerging evidence generated.
Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways / Faulkner, S. D.; Lee, M.; Qin, D.; Morrell, L.; Xoxi, E.; Sammarco, A.; Cammarata, S.; Russo, P.; Pani, L.; Barker, R.. - In: CLINICAL PHARMACOLOGY & THERAPEUTICS. - ISSN 0009-9236. - 100:6(2016), pp. 730-742. [10.1002/cpt.508]
Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways
Pani, L.Conceptualization
;
2016
Abstract
Earlier patient access to beneficial therapeutics that addresses unmet need is one of the main requirements of innovation in global healthcare systems already burdened by unsustainable budgets. “Adaptive pathways” encompass earlier cross-stakeholder engagement, regulatory tools, and iterative evidence generation through the life cycle of the medicinal product. A key enabler of earlier patient access is through more flexible and adaptive payer approaches to pricing and reimbursement that reflect the emerging evidence generated.File | Dimensione | Formato | |
---|---|---|---|
Scaling up health knowledge at European level requires sharing integrated data- an approach for collection of database specification CEOR-97548.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
561.05 kB
Formato
Adobe PDF
|
561.05 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris